• Rakovina Therapeutics closed a first tranche of a non-brokered private placement, raising gross proceeds of $1.39 million.
• Issued 13,940,000 units at $0.1 per unit, each with one share plus a half-warrant.
• Upsized the offering to up to $2 million from $1.5 million, extending the deadline to Sept. 10, 2026.
• Warrants carry a $0.2 exercise price, expiring 24 months from issuance.
• Insiders bought 1,900,000 units for $190,000; cash finder’s fees totaled $85,315 with 853,150 finder’s units issued.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rakovina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608120400PRIMZONEFULLFEED9808422) on August 12, 2026, and is solely responsible for the information contained therein.